Portugal's INFARMED authorized Tilray Medical's Cantanhede facility to conduct microbiological and chemical/physical testing on-site. The move cuts third-party dependency, lowers batch-release costs, and speeds product to market in regulated European medical cannabis markets.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
